| Literature DB >> 34362795 |
Junge Deng1, Jialiang Zhang1, Ying Ye1, Kaijing Liu1, Lingxing Zeng1, Jingyi Huang1, Ling Pan1, Mei Li2, Ruihong Bai1, Lisha Zhuang1, Xudong Huang1, Guandi Wu1, Lusheng Wei3, Yanfen Zheng1, Jiachun Su1, Shaoping Zhang1, Rufu Chen4, Dongxin Lin5,6,7, Jian Zheng5,7.
Abstract
Pseudogenes may play important roles in cancer. Here, we explore the mechanism and function of a pseudogene WTAPP1 in the progress of pancreatic ductal adenocarcinoma (PDAC). WTAPP1 RNA was significantly elevated in PDAC and was associated with poor prognosis in patients. Overexpression of WTAPP1 RNA promoted PDAC proliferation and invasiveness in vitro and in vivo. Mechanistically, N 6-methyladenosine (m6A) modification stabilized WTAPP1 RNA via CCHC-type zinc finger nucleic-acid binding protein (CNBP), resulting in increased levels of WTAPP1 RNA in PDAC cells. Excessive WTAPP1 RNA bound its protein-coding counterpart WT1-associated protein (WTAP) mRNA and recruited more EIF3 translation initiation complex to promote WTAP translation. Increased WTAP protein enhanced the activation of Wnt signaling and provoked the malignant phenotypes of PDAC. Decreasing WTAPP1 RNA significantly suppressed the in vivo growth and metastasis of PDAC cell lines and patient-derived xenografts. These results indicate that m6A-mediated increases in WTAPP1 expression promote PDAC progression and thus may serve as a therapeutic target. SIGNIFICANCE: This study reveals how aberrant m6A modification of the WTAPP1 pseudogene results in increased translation of its protein-coding counterpart to promote Wnt signaling, which contributes to pancreatic cancer progression. ©2021 The Authors; Published by the American Association for Cancer Research.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34362795 DOI: 10.1158/0008-5472.CAN-21-0494
Source DB: PubMed Journal: Cancer Res ISSN: 0008-5472 Impact factor: 12.701